SWOT Analysis for Sun Pharmaceutical Industries Ltd. - Weakness

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Stocks with Consistent Share Price Growth (subscription)

Rising Net Cash Flow and Cash from Operating activity

Expensive Performers (DVM)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Stocks in uptrend most likely to cross above SMA-200 soon

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Increasing Trend in Non-Core Income

High promoter stock pledges

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Street Favorite: High Analyst Rating with at least 20% upside

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Broker price or reco upgrades in last month

Red Flags: Firms linked to ongoing regulatory investigations/legal cases

High Piotroski Score - Companies with strong financials

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)